Design, synthesis and anti-Alzheimer’s activity of novel 1,2,3-triazole-chromenone carboxamide derivatives

Plassman, 2007, Prevalence of dementia in the United States: the aging, demographics, and memory study, Neuroepidemiology, 29, 125, 10.1159/000109998

Oakley, 2006, Intraneuronal β-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation, J. Neurosci., 26, 10129, 10.1523/JNEUROSCI.1202-06.2006

LaFerla, 2007, Intracellular amyloid-β in Alzheimer's disease, Nature Rev. Neurosci., 8, 499, 10.1038/nrn2168

Bush, 2013, The metal theory of Alzheimer's disease, J. Alzheimers Dis., 33, S277

Robert, 2015, Regulation of c and iron homeostasis by metal chelators: a possible chemotherapy for Alzheimer’s disease, Acc. Chem. Res., 48, 1332, 10.1021/acs.accounts.5b00119

Mattson, 1993, Calcium-destabilizing and neurodegenerative effects of aggregated beta-amyloid peptide are attenuated by basic FGF, Brain Res., 621, 35, 10.1016/0006-8993(93)90295-X

Di Bona, 2010, Immune-inflammatory responses and oxidative stress in Alzheimer's disease: therapeutic implications, Curr. Pharm. Des., 16, 684, 10.2174/138161210790883769

Ferreira-Vieira, 2016, Alzheimer's disease: targeting the sholinergic system, Curr. Neuropharmacol., 14, 101, 10.2174/1570159X13666150716165726

Talaga, 2001, β-Amyloid aggregation inhibitors for the treatment of Alzheimer’s disease: dream or reality, Mini Rev. Med. Chem., 1, 175, 10.2174/1389557013407098

Castro, 2000, Inhibition of tau phosphorylation: a new therapeutic strategy for the treatment of Alzheimer’s disease and other, Expert Opin. Ther. Pat., 10, 1519, 10.1517/13543776.10.10.1519

Wilkinson, 2004, Cholinesterase inhibitors used in the treatment of Alzheimer’s disease, Drugs Aging, 21, 453, 10.2165/00002512-200421070-00004

Wessler, 2008, Acetylcholine beyond neurons: the non-neuronal cholinergic system in humans, Br. J. Pharmacol., 154, 1558, 10.1038/bjp.2008.185

Bartolucci, 2010, Probing Torpedo californica acetylcholinesterase catalytic gorge with two novel bis-functional galanthamine derivatives, J. Med. Chem., 53, 745, 10.1021/jm901296p

Pohanka, 2012, Acetylcholinesterase inhibitors: a patent review (2008- present), Expert Opin. Ther. Pat., 22, 1354, 10.1517/13543776.2012.701620

Gabrielle, 2003, Cytosolic choline acetyltransferase binds specifically to cholinergic plasma membrane of rat brain synaptosomes to generate membrane-bound enzyme, Neurochem. Res., 28, 543, 10.1023/A:1022825407631

Gupta, 2011, 3D-Pharmacophore model based virtual screening to identify dual-binding site and selective acetylcholinesterase inhibitors, Med. Chem. Res., 20, 1422, 10.1007/s00044-010-9373-7

Nordberg, 2000, Neuroprotection in Alzheimer's disease - new strategies for treatment, Neurotox. Res., 2, 157, 10.1007/BF03033791

Craiga, 2011, Revisiting the cholinergic hypothesis in the development of Alzheimer’s disease, Neurosci. Biobehav. Rev., 35, 1397, 10.1016/j.neubiorev.2011.03.001

Saeedi, 2017, Synthesis of novel chromenones linked to 1,2,3-triazole ring system: investigation of biological activities against Alzheimer’s disease, Bioorg. Chem., 70, 86, 10.1016/j.bioorg.2016.11.011

Saeedi, 2016, Phthalimide-Derived N-benzylpyridinium halides targeting cholinesterases: synthesis and bioactivity of new potential anti-Alzheimer's disease agents, Arch. Pharm., 349, 293, 10.1002/ardp.201500425

Najafi, 2017, Novel tacrine-1,2,3-triazole hybrids: in vitro, in vivo biological evaluation and docking study of cholinesterase inhibitors, Eur. J. Med. Chem., 125, 1200, 10.1016/j.ejmech.2016.11.008

Najafi, 2016, Design and synthesis of novel anti-Alzheimer’s agents: Acridine-chromenone and quinoline-chromenone hybrids, Bioorg. Chem., 67, 84, 10.1016/j.bioorg.2016.06.001

Sameem, 2017, Synthesis, docking study and neuroprotective effects of some novel pyrano[3,2-c]chromene derivatives bearing morpholine/phenylpiperazine moiety, Bioorg. Med. Chem., 25, 3980, 10.1016/j.bmc.2017.05.043

Hariri, 2016, Novel tacrine-based pyrano[3’,4’:5,6]pyrano[2,3-b]quinolinones: synthesis and cholinesterase inhibitory activity, Arch. Pharm., 349, 915, 10.1002/ardp.201600123

Anand, 2012, A review on coumarins as acetylcholinesterase inhibitors for Alzheimer’s disease, Bioorg. Med. Chem., 20, 1175, 10.1016/j.bmc.2011.12.042

Marumoto, 2012, Structure–activity relationships for naturally occurring coumarins as β-secretase inhibitor, Bioorg. Med. Chem., 20, 784, 10.1016/j.bmc.2011.12.002

Lewis, 2002, Click chemistry in situ: acetylcholinesterase as a reaction vessel for the selective assembly of a femtomolar inhibitor from an array of building blocks, Angew. Chem. Int. Ed., 41, 1053, 10.1002/1521-3773(20020315)41:6<1053::AID-ANIE1053>3.0.CO;2-4

Mamidyala, 2010, In situ click chemistry: probing the binding landscapes of biological molecules, Chem. Soc. Rev., 39, 1252, 10.1039/b901969n

Hoerr, 2002, Ensaculin (KA-672-HCl): a multitransmitter approach to dementia treatment, CNS Drug Rev., 8, 143, 10.1111/j.1527-3458.2002.tb00220.x

Asadipour, 2013, Novel coumarin-3-carboxamides bearing N-benzylpiperidine moiety as potent acetylcholinesterase inhibitors, Eur. J. Med. Chem., 70, 623, 10.1016/j.ejmech.2013.10.024

Iraji, 2017, Multifunctional iminochromene-2H-carboxamide derivatives containing different aminomethylene triazole with BACE1 inhibitory, neuroprotective and metal chelating properties targeting Alzheimer's disease, Eur. J. Med. Chem., 141, 690, 10.1016/j.ejmech.2017.09.057

Ellman, 1961, A new and rapid colorimetric determination of acetylcholinesterase activity, Biochem. Pharmacol., 71, 88, 10.1016/0006-2952(61)90145-9

Saeedi, 2015, Synthesis of novel 1,2,3-triazole-dihydro[3,2-c]chromenones as acetylcholinesterase inhibitors, Synth. Commun., 45, 2311, 10.1080/00397911.2015.1077971

Rodríguez-Rodríguez, 2012, The art of building multifunctional metal-binding agents from basic molecular scaffolds for the potential application in neurodegenerative diseases, Coord. Chem. Rev., 256, 2308, 10.1016/j.ccr.2012.03.008

Qiang, 2014, Design, synthesis and evaluation of genistein-O-alkylbenzylamines as potential multifunctional agents for the treatment of Alzheimer’s disease, Eur. J. Med. Chem., 76, 314, 10.1016/j.ejmech.2014.02.045

Trott, 2010, AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading, J. Comput. Chem., 31, 455

O’Boyle, 2011, Open Babel: An open chemical toolbox, J. Cheminform, 3, 33, 10.1186/1758-2946-3-33

Sanner, 1999, A programming language for softwa re integration and development, J. Mol. Graph. Model., 17, 57